跳至主要内容
临床试验/NL-OMON39948
NL-OMON39948已完成不适用

Rosuvastatin use to improve the coagulation profile in patients with venous thrombosis: The STAtins Reduce Thrombophilia (START) Study - START

eids Universitair Medisch Centrum0 个研究点目标入组 250 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Persons with venous thrombosis who are allowed to discontinue oral anticoagulant treatment by their treating physician and do not receive a statin.

排除标准

  • Persons already using statins or lipid lowering drugs
  • History of statin-induced myopathy, or serious hypersensitivity reaction to other HMG-CoA reductase inhibitors (statins), including rosuvastatin
  • Current active liver disease
  • Kidney disease
  • Mental or physical disability to fulfil study requirements

研究者

相似试验